Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Cosmo Pharmaceuticals N.V.    COPN   NL0011832936

COSMO PHARMACEUTICALS N.V.

(COPN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
All news about COSMO PHARMACEUTICALS N.V.
12/01Cosmo Pharmaceuticals appoints new Chief Medical Officer
TE
12/01Cosmo Pharmaceuticals ernennt neuen Chief Medical Officer
TE
11/24COSMO PHARMACEUTICALS N : Announces Senior Leadership Changes
AQ
11/23Cosmo Pharmaceuticals Announces Senior Leadership Changes
TE
11/23Cosmo Pharmaceuticals kündigt Wechsel im Führungsteam an
TE
11/20COSMO PHARMACEUTICALS N : announces expansion of agreement with Dr. Falk Pharma ..
AQ
11/19Cosmo Pharmaceuticals announces expansion of agreement with Dr. Falk Pharma f..
TE
11/18COSMO PHARMACEUTICALS N : announces approval of Eleview in Japan
AQ
11/17Cosmo Pharmaceuticals announces approval of Eleview® in Japan
TE
10/12COSMO PHARMACEUTICALS N : Acacia Pharma completes drawdown from EUR25 million lo..
AQ
08/28COSMO PHARMACEUTICALS N : announces FDA Approval for Cassiopea's Winlevi, First-..
AQ
08/27Cassiopea gets U.S. FDA approval for acne treatment Winlevi
RE
08/27COSMO PHARMACEUTICALS N : announces FDA Approval for Cassiopea's Winlevi ® (clas..
PU
08/27Cosmo Pharmaceuticals announces FDA Approval for Cassiopea's Winlevi® (clasco..
TE
08/24COSMO PHARMACEUTICALS N : NV - Methylene Blue MMX approved in Europe for the vis..
AQ
08/21Methylene Blue MMX approved in Europe for the visualization of colorectal les..
TE
08/13REDHILL BIOPHARMA : and Cosmo Pharmaceuticals to Expand Strategic Partnership wi..
AQ
08/13Cosmo and RedHill Biopharma to Expand Strategic Partnership with Exclusive Li..
TE
07/30Cosmo Half-Year Report 2020
TE
07/15Cosmo Pharmceuticals assigns US license agreement for BYFAVOTM (remimazolam) ..
TE
07/09COSMO PHARMACEUTICALS N : announces granting of Marketing Authorization in Italy..
AQ
07/08Cosmo Pharmaceuticals announces granting of Marketing Authorization in Italy ..
TE
07/03Acacia Pharma Announces US FDA Approval of BYFAVO for injection for the Induc..
AQ
07/02Cosmo Pharmaceuticals Announces US FDA Approval of BYFAVO™ (remimazolam..
TE
07/01Cosmo Pharmaceuticals Appoints new CSO
TE
06/29COSMO PHARMACEUTICALS N : receives positive EMA CHMP Opinion recommending approv..
AQ
06/26Cosmo receives positive EMA CHMP Opinion recommending approval of Methylene B..
TE
06/24COSMO PHARMACEUTICALS N : announces regulatory approval of GI GENIUS in Israel
AQ
06/23Cosmo gibt die behördliche Genehmigung für GI-Genius™ in Israel bekannt
TE
06/23Cosmo announces regulatory approval of GI GENIUS™ in Israel
TE
06/15COSMO PHARMACEUTICALS N : announces United Arab Emirates regulatory approval of ..
AQ
06/12Cosmo announces United Arab Emirates regulatory approval of GI GENIUS™
TE
06/01Cosmo Pharmaceuticals increases its stake in Acacia Pharma to 18.53%
TE
05/29Cosmo Pharmaceuticals' Shareholders approve all Agenda Items at Annual Genera..
TE
04/07COSMO PHARMACEUTICALS N : announces Italian Approval for Compassionate Use of Re..
AQ
04/06COSMO PHARMACEUTICALS N : Full-Year Report 2019
AQ
04/06Cosmo Pharmaceuticals announces RedHill's Approval of Compassionate Use of Op..
TE
04/03COSMO PHARMACEUTICALS N : Methylene Blue MMX regulatory update, filing of protoc..
AQ
04/03Cosmo Full-Year Report 2019
TE
04/02COSMO PHARMACEUTICALS METHYLENE BLUE : filing of protocol for confirmatory phase..
TE
03/31COSMO PHARMACEUTICALS N.V. : annual earnings release
03/25COSMO PHARMACEUTICALS N : Acacia Pharma Group plc - Publication of Prospectus
AQ
03/12Cosmo announces Brief Extension of FDA Review Period for NDA for BYFAVO&trade..
TE
03/12Cosmo Pharmaceuticals gibt kurze Verlängerung des FDA Untersuchungszeitraums ..
TE
03/12Cosmo announces the resignation of CSO Roberto Camerini
TE
03/03COSMO PHARMACEUTICALS N : Acacia Pharma Group plc - Results for the year ended 3..
AQ
03/02COSMO PHARMACEUTICALS N : announces Australian regulatory approval of GI GENIUS
AQ
02/28COSMO PHARMACEUTICALS N : announces that Acacia Pharma Group plc obtains U.S. FD..
AQ
02/28Cosmo announces Australian regulatory approval of GI GENIUS™
TE
02/27Cosmo announces that Acacia Pharma Group plc obtains U.S. FDA Approval of BAR..
TE
02/24Cosmo Pharmaceuticals announces the retirement of Chris Tanner from executive..
TE
02/20Cosmo announces very successful outcome of first GI GENIUS™ Investigato..
TE
01/22COSMO PHARMACEUTICALS N : Methylene Blue MMX regulatory update Substantial align..
AQ
01/21COSMO PHARMACEUTICALS METHYLENE BLUE : Substantial alignment reached with FDA on..
TE
01/13Acacia Pharma enters into strategic in-licensing, investment and loan transac..
AQ
01/13Cosmo sub-licenses its ByFavo US rights to Acacia Pharma, takes an initial 14..
AQ
01/10Boeing faces fresh scandal
01/10Cosmo sub-licenses its ByFavo™ (Remimazolam) US rights to Acacia Pharma..
TE
2019RedHill Biopharma Initiates U.S. Promotion of Aemcolo for Travelers' Diarrhea
AQ
2019COSMO PHARMACEUTICALS N : announces worldwide exclusive Distribution Agreement f..
AQ
2019Cosmo Pharmaceuticals announces worldwide exclusive Distribution Agreement fo..
TE
2019COSMO PHARMACEUTICALS N : appoints New CSO; as current CSO retires
PU
2019Cosmo appoints New CSO as current CSO retires
TE
2019Cosmo's Partner RedHill gibt die Zulassung von Talicia® für die Behandlung vo..
TE
2019Cosmo's Partner RedHill announces approval of Talicia® for the treatment of H..
TE
2019Cosmo licenses Aemcolo™ for the USA to RedHill Biopharma and takes a 19..
TE
2019Cosmo Half-Year Report 2019
TE
2019Cosmo Pharmaceuticals Posts GI Genius Video Demonstration at Image 2019 Confe..
TE
2019Cosmo Pharmaceuticals announces Canadian Agency approval of Eleview® for endo..
TE
2019Cosmo Pharmaceuticals announces Publication of Review of Aemcolo™ as Tr..
TE
2019FDA accepts filing of NDA for Remimazolam
TE
2019Cosmo Pharmaceuticals' Shareholders approve all Agenda Items at Annual Genera..
TE
2019COSMO PHARMACEUTICALS : New exclusive Distribution Agreement for Eleview with Me..
TE
2019COSMO PHARMACEUTICALS : FDA Allowance of IND application for CB-03-10
TE
2019Cosmo Pharmaceuticals announces agenda of the R&D Day 2019
TE
1  2  3Next
Upcoming event on COSMO PHARMACEUTICALS N.V.